Search
Alnylam CEO Yvonne Greenstreet on today's HELIOS-B data
- blonca9
- Jun 24, 2024
- 1 min read
Yvonne Greenstreet shares her thoughts on key points of today's top-line, but as monotherapy and in combination, the potential market, and what this means for Alnylam more broadly.